Pharmaceutical and Biotech Expert Joins NUI Galway Technology Transfer Office
Monday, 15 September 2008
Pharmaceutical and biotech business leader, Dr John Kavanagh, has taken over as NUI Galway's Director of Technology Transfer. He will work with the University's Ignite Technology Transfer Office to commercialise and license the work of researchers on campus. Dr Kavanagh will also further develop the University's partnerships with industry and the business community. Dr Kavanagh joins NUI Galway from Bioniche Teoranta, a company based in Inverin, Co. Galway, specialising in sterile injectables, where he was Managing Director for five years. Previously, he occupied senior positions at Abbott Laboratories, Sandoz/Novartis and Schering-Plough. Speaking about his new role, Dr Kavanagh said: "NUI Galway was the first University in Ireland to create a dedicated technology transfer office. I look forward to building on the excellent work that has already taken place." He added: "Never more so, than when there is an economic downturn, does the entrepreneurial approach to business need to be nurtured. The University, with its world-leading research and strong industry partnerships is well positioned to continue its technology commercialisation success." So far this year, the University's Ignite Technology Transfer Office has filed 42 invention disclosures, 15 patents and licensed six technologies to industry. Professor Terry Smith, Vice-President for Research at NUI Galway, welcomed Dr Kavanagh to the University: "John brings with him a wealth of experience in all aspects of technology transfer and the commercialisation of research. He will, no doubt, lead the further development and growth of the Ignite Technology Transfer Office in the coming years." Originally from Dublin, Dr Kavanagh is a graduate of UCD, having completed a B.Sc. degree in Chemistry and a Ph.D. in Organic Chemistry. He also holds a Diploma in Applied Finance from the Irish Management Institute.